Search - tctmd.com

Displaying 701 - 720 of 1385

Sort: Relevancy | Date

News Conference News ESC 2019

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

Todd Neale

September 04, 2019

News Conference News ESC 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Michael O'Riordan

September 03, 2019

News Conference News ESC 2019

CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients

Shelley Wood

September 03, 2019

Presentation ESC 2019

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Presenter: Johannes Neumann

September 01, 2019

News Conference News ESC 2019

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

Shelley Wood

September 01, 2019

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Daily News

Substantial Increase in PCI Survival Over 10 Years: Single Center

Yael L. Maxwell

August 16, 2019

News Daily News

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

Yael L. Maxwell

August 08, 2019

News Daily News

Stroke After PCI: Rare but Rising as Patient Complexity Climbs

Todd Neale

August 05, 2019

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Shelley Wood

August 05, 2019

Presentation CHIP Seattle 2019

CHIP 2.0:Where We Need to Go Next

Presenter: Ajay J. Kirtane

August 03, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: The Push for High-Sensitivity Troponin

August 02, 2019

Presentation CHIP Seattle 2019

Coronary Perforations Wire Across

Presenter: Megha Prasad

August 02, 2019

News Daily News

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Caitlin E. Cox

July 25, 2019

News Daily News

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

Marcus A. Banks

July 24, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

Presentation SCCT 2019

Latest Insights From SCOT-HEART Sub-studies

Presenter: David Newby

July 11, 2019

News Opinion Fellow Talk

Hemodynamics: The Forgotten Branch of Cardiology

Mesfer Alfadhel, MD

June 28, 2019

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

Advertisement

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Substantial Increase in PCI Survival Over 10 Years: Single Center

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

Stroke After PCI: Rare but Rising as Patient Complexity Climbs

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

CHIP 2.0:Where We Need to Go Next

Conversations in Cardiology: The Push for High-Sensitivity Troponin

Coronary Perforations Wire Across

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Latest Insights From SCOT-HEART Sub-studies

Hemodynamics: The Forgotten Branch of Cardiology

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content